| scholarly article | Q13442814 |
| P2093 | author name string | Anna Campanati | |
| Annamaria Offidani | |||
| Giulia Ganzetti | |||
| Roberto Di Primio | |||
| Monia Orciani | |||
| Veronica Consales | |||
| P2860 | cites work | The Dermatology Life Quality Index: assessing the efficacy of biological therapies for psoriasis | Q36771864 |
| Angiogenesis drives psoriasis pathogenesis | Q37534974 | ||
| Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis | Q37724124 | ||
| Immunogenicity of anti-TNFα therapy in psoriasis: a clinical issue? | Q38150903 | ||
| Oxidative stress defense in human-skin-derived mesenchymal stem cells versus human keratinocytes: Different mechanisms of protection and cell selection | Q42472754 | ||
| Functional characterization of calcium-signaling pathways of human skin-derived mesenchymal stem cells. | Q43201756 | ||
| Pronounced and early acne in Apert's syndrome: a case successfully treated with oral isotretinoin | Q44172064 | ||
| Lichen striatus in adults and pimecrolimus: open, off-label clinical study | Q46493311 | ||
| The effect of etanercept on hepatic fibrosis risk in patients with non-alcoholic fatty liver disease, metabolic syndrome, and psoriasis. | Q51350319 | ||
| Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation. | Q51633446 | ||
| Effect of biologic therapies targeting tumour necrosis factor-α on cutaneous mesenchymal stem cells in psoriasis | Q57272045 | ||
| Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment | Q80608470 | ||
| Human skin-derived mesenchymal stem cells as a source of VEGF and nitric oxide | Q82341634 | ||
| The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity | Q83630245 | ||
| The mesenchymal stem cell profile in psoriasis | Q84220007 | ||
| Alopecia Areata: a possible extraintestinal manifestation of Crohn's disease | Q84444125 | ||
| A patient with psoriasis and vitiligo treated with etanercept | Q84497534 | ||
| Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17/Th2 imbalance of psoriasis | Q87668292 | ||
| P433 | issue | 1 suppl | |
| P921 | main subject | endothelium | Q111140 |
| mesenchymal stem cell | Q1922379 | ||
| P304 | page(s) | 6-9 | |
| P577 | publication date | 2016-09-01 | |
| P1433 | published in | Journal of International Medical Research | Q15758331 |
| P1476 | title | The effect of etanercept on vascular endothelial growth factor production by cutaneous mesenchymal stem cells from patients with psoriasis | |
| P478 | volume | 44 |
| Q64070793 | Anti-TNF- αtreatment-related pathways and biomarkers revealed by transcriptome analysis in Chinese psoriasis patients |
| Q49586531 | Anti-angiogenic effects of biotechnological therapies in rheumatic diseases |
| Q64242901 | Dermal mesenchymal stem cells: a resource of migration-associated function in psoriasis? |
| Q92308003 | Mesenchymal Stromal Cells from the Epidermis and Dermis of Psoriasis Patients: Morphology, Immunophenotype, Differentiation Patterns, and Regulation of T Cell Proliferation |
| Q58785751 | Psoriasis, Cardiovascular Events, and Biologics: Lights and Shadows |
| Q87660254 | Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives |
Search more.